326 related articles for article (PubMed ID: 29992269)
1. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
2. The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis.
Govender MA; Fabian J; Gottlich E; Levy C; Moonsamy G; Maher H; Winkler CA; Ramsay M
Commun Biol; 2019; 2():416. PubMed ID: 31754646
[TBL] [Abstract][Full Text] [Related]
3. APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation.
Servais A; Gribouval O; Gaillard F; Antignac C
Nephrol Ther; 2019 Apr; 15 Suppl 1():S85-S89. PubMed ID: 30981401
[TBL] [Abstract][Full Text] [Related]
4. APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses.
Watanabe A; Guaragna MS; Belangero VMS; Casimiro FMS; Pesquero JB; de Santis Feltran L; Palma LMP; Varela P; de Menezes Neves PDM; Lerario AM; de Souza ML; de Mello MP; de Brito Lutaif ACG; Ferrari CR; Sampson MG; Onuchic LF; Nogueira PCK
Pediatr Nephrol; 2021 Aug; 36(8):2327-2336. PubMed ID: 33585978
[TBL] [Abstract][Full Text] [Related]
5. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
Nandlal L; Winkler CA; Bhimma R; Cho S; Nelson GW; Haripershad S; Naicker T
Eur J Pediatr; 2022 Oct; 181(10):3595-3606. PubMed ID: 35920919
[TBL] [Abstract][Full Text] [Related]
6. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG
Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333
[TBL] [Abstract][Full Text] [Related]
7. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.
Gribouval O; Boyer O; Hummel A; Dantal J; Martinez F; Sberro-Soussan R; Etienne I; Chauveau D; Delahousse M; Lionet A; Allard J; Pouteil Noble C; Tête MJ; Heidet L; Antignac C; Servais A
Kidney Int; 2018 Nov; 94(5):1013-1022. PubMed ID: 30348286
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
Adeyemo A; Esezobor C; Solarin A; Abeyagunawardena A; Kari JA; El Desoky S; Greenbaum LA; Kamel M; Kallash M; Silva C; Young A; Hunley TE; de Jesus-Gonzalez N; Srivastava T; Gbadegesin R
Am J Kidney Dis; 2018 Mar; 71(3):399-406. PubMed ID: 29277510
[TBL] [Abstract][Full Text] [Related]
9. Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.
Vivante A; Chacham OS; Shril S; Schreiber R; Mane SM; Pode-Shakked B; Soliman NA; Koneth I; Schiffer M; Anikster Y; Hildebrandt F
Pediatr Nephrol; 2019 Sep; 34(9):1607-1613. PubMed ID: 31001663
[TBL] [Abstract][Full Text] [Related]
10. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
Zee J; McNulty MT; Hodgin JB; Zhdanova O; Hingorani S; Jefferson JA; Gibson KL; Trachtman H; Fornoni A; Dell KM; Reich HN; Bagnasco S; Greenbaum LA; Lafayette RA; Gipson DS; Brown E; Kretzler M; Appel G; Sambandam KK; Tuttle KR; Chen D; Atkinson MA; Hogan MC; Kaskel FJ; Meyers KE; O'Toole J; Srivastava T; Sethna CB; Hladunewich MA; Lin JJ; Nast CC; Derebail VK; Patel J; Vento S; Holzman LB; Athavale AM; Adler SG; Lemley KV; Lieske JC; Hogan JJ; Gadegbeku CA; Fervenza FC; Wang CS; Matar RB; Singer P; Kopp JB; Barisoni L; Sampson MG
Pediatr Nephrol; 2021 Sep; 36(9):2747-2757. PubMed ID: 33646395
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.
Bullich G; Trujillano D; Santín S; Ossowski S; Mendizábal S; Fraga G; Madrid Á; Ariceta G; Ballarín J; Torra R; Estivill X; Ars E
Eur J Hum Genet; 2015 Sep; 23(9):1192-9. PubMed ID: 25407002
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
Santín S; Tazón-Vega B; Silva I; Cobo MÁ; Giménez I; Ruíz P; García-Maset R; Ballarín J; Torra R; Ars E;
Clin J Am Soc Nephrol; 2011 Feb; 6(2):344-54. PubMed ID: 20947785
[TBL] [Abstract][Full Text] [Related]
13. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
14. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
[TBL] [Abstract][Full Text] [Related]
15. Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.
Sharif B; Barua M
Curr Opin Nephrol Hypertens; 2018 May; 27(3):194-200. PubMed ID: 29465426
[TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
17. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.
Laurin LP; Lu M; Mottl AK; Blyth ER; Poulton CJ; Weck KE
Nephrol Dial Transplant; 2014 Nov; 29(11):2062-9. PubMed ID: 24500309
[TBL] [Abstract][Full Text] [Related]
19. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
[TBL] [Abstract][Full Text] [Related]
20. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.
Gigante M; Caridi G; Montemurno E; Soccio M; d'Apolito M; Cerullo G; Aucella F; Schirinzi A; Emma F; Massella L; Messina G; De Palo T; Ranieri E; Ghiggeri GM; Gesualdo L
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1626-34. PubMed ID: 21734084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
